| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | See Remarks | Chief Financial Officer
1 company
Notman Donald is a Chief Operating Officer at OCUL. Recent filings cover 3 purchases and 10 sales. Those positions are worth an estimated $3.8M at current prices.
Our model assigns Notman Donald a below-average insider score of 35/100, based on 6 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -32.9%.
Notman Donald's largest disclosed position is in OCUL as Chief Operating Officer, worth about $3.8M. The recent filings there lean toward selling, a net 41,842 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2017 | OCUL Ocular Therapeutix, Inc | Chief Financial Officer | Buy | 4,800 | $4.00 | $19,200.00 | New |